Please use this identifier to cite or link to this item:
Title: Analysis of a Novel pncA Mutation for Susceptibility to Pyrazinamide Therapy.
Austin Authors: Karmakar, Malancha;Globan, Maria;Fyfe, Janet A M;Stinear, Timothy P;Johnson, Paul D R ;Holmes, Natasha E ;Denholm, Justin T;Ascher, David B
Affiliation: University of Melbourne Bio21 Molecular Science and Biotechnology Institute, Department of Biochemistry and Molecular Biology, Parkville, Victoria, Australia
University of Melbourne, Victorian Tuberculosis Program, Melbourne Health, Melbourne, Victoria, Australia
Doherty Institute for Infection and Immunity, Department of Microbiology and Immunology , Melbourne, Victoria, Australia
Victorian Infectious Diseases Reference Laboratory (VIDRL), Mycobacterium Reference Laboratory, Melbourne, Victoria, Australia
World Health Organization Collaborating Centre for Mycobacterium ulcerans, Melbourne, Victoria, Australia
Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia
Victorian Infectious Diseases Service and Department of Microbiology and Immunology, at the Peter Doherty Institute for Infection and Immunity,, Parkville, Australia
University of Cambridge, Department of Biochemistry, Cambridge, Cambridgeshire, United Kingdom of Great Britain and Northern Ireland
Issue Date: 25-Apr-2018 2018-04-25
Publication information: American Journal of Respiratory and Critical Care Medicine 2018; 198(4): 541-544
DOI: 10.1164/rccm.201712-2572LE
ORCID: 0000-0003-2948-2413
PubMed URL: 29694240
Type: Journal Article
Subjects: Pyrazinamide resistance
Structural bioinformatics
Tuberculosis treatment
pncA mutations
Appears in Collections:Journal articles

Show full item record

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.